论文部分内容阅读
选取2011年9月~2013年9月我院收治的肝硬化患者90例,随机分为观察组和对照组各45例。观察组在常规治疗基础上联合前列腺素E1进行治疗,对照组仅选用常规方法进行治疗,观察并比较两组患者临床疗效及各肝功能指标改善情况。结果观察组临床疗效优良率为73.3%,对照组为51.1%,两组患者临床疗效比较差异有统计学意义(P<0.05);观察组各肝功能指标改善情况均明显优于对照组,比较差异有统计学意义(P<0.05)。前列腺素E1治疗肝硬化的临床疗效好,能有效改善患者肝功能,值得在临床上予以推广。
90 patients with cirrhosis admitted in our hospital from September 2011 to September 2013 were randomly divided into observation group and control group, 45 cases each. The observation group was treated with prostaglandin E1 on the basis of routine treatment. The control group was treated by conventional method only. The clinical curative effect and the improvement of each liver function index of the two groups were observed and compared. Results The excellent and good rate of clinical curative effect was 73.3% in the observation group and 51.1% in the control group. There was significant difference between the two groups in the clinical curative effect (P <0.05). The improvement of each liver function index in the observation group was better than that in the control group The difference was statistically significant (P <0.05). Prostaglandin E1 for the treatment of cirrhosis of the clinical efficacy, can effectively improve the patient’s liver function, it is worth to be promoted in the clinic.